Position in RDY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$277,280
+$62,439 QoQ
Shares Held
19,136
+23.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#141
of 238 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HB Wealth Management, LLC holds $9,010,122 across 12 Drug Manufacturers - Specialty & Generic names. RDY ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
38,820 | $2,789,605 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,331 | $1,263,005 | |
| 3 | HLN |
Haleon plc
|
133,227 | $1,243,007 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
7,323 | $1,234,218 | |
| 5 | VTRS |
Viatris Inc
|
58,985 | $936,681 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,693 | $294,518 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
This page
|
19,136 | $277,280 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
11,108 | $273,367 |
All Filings in RDY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,280 | 19,136 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $214,841 | 15,512 | Shares | Sole | 2026-04-27 | |
| 2025-06-30 | $181,111 | 12,050 | Shares | Sole | 2025-07-17 | |
| No filing history on record for this holder in this stock. | ||||||